|Articles|September 1, 2015
- BioPharm International-09-01-2015
- Volume 28
- Issue 9
BioPharm International, September 2015 Issue (PDF)
Click the title above to open the BioPharm International September 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
Stability Testing in Biopharmaover 10 years ago
Contract Biomanufacturing Firms Become More Specializedover 10 years ago
Enhancing Protein Binding Studies with a Light-Scattering Toolkitover 10 years ago
Utilizing Run Rules for Effective Monitoring in Manufacturingover 10 years ago
Manufacturers Face Key Policy and Regulatory Challengesover 10 years ago
CMOs Concerned With Cost of Single-Use Equipmentover 10 years ago
Biocontainer Assemblies Provide Repeatable Performanceover 10 years ago
Best Practices in Qualification of Single-Use Systemsover 10 years ago
The Metrics of Quality Cultureover 10 years ago
Data Integrity: Getting Back to BasicsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
